Buy Aurobindo Pharma; target of Rs 900: Motilal Oswal Business Business / Business 6 years ago 516 Views comments Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 900 in its research report dated May 09... Read more
Business NSE's IPO may be delayed | एनएसई के आईपीओ में देरी हो सकती है Business / Business - 6 years ago
Business Fast Money: Know how US Tax reform could hit Indian stock market Business / Business - 6 years ago
Business PM Modi sternly warns cow vigilantes in all-party meet ahead of Parliament's monsoon session Business / Business - 6 years ago
Business Government prepares for revival of projects stuck for more than 5 years Business / Business - 6 years ago
Business Now travel on national highways without stopping at toll plazas via FASTag lanes Business / Business - 6 years ago
Comments